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Solving the Eating Disorders Puzzle Piece by 
Piece
Cynthia M. Bulik and Gerome BreenAlbeit slowly, we are beginning to piece together the complex
biological puzzle of anorexia nervosa (AN), bulimia nervosa
(BN), and binge eating disorder (BED). The article by Lutter
et al. (1) in this issue of Biological Psychiatry brings us one
step closer to understanding these illnesses.
To set the stage, heritability estimates for all three eating
disorders range from 40% to 65% with a smaller but still
considerable environmental contribution to risk (2). However,
the overwhelming predominance of sociocultural explanations
and rationalizations has meant there have been comparatively
few investigations into the biological underpinnings of these
anomalous conditions. AN is a particularly perplexing illness,
primarily, but not exclusively, affecting young women, compel-
ling them into prolonged negative energy balance, often to the
point of death.
To uncover the biological causes of eating disorders,
multiple approaches are required. In genetics, the field is
advancing with genome-wide association studies of AN, with
the first genome-wide significant locus having recently been
identified (3) in a gene previously associated with type 1
diabetes and other autoimmune conditions. This work also
suggests a previously overlooked role for metabolic abnorm-
alities in the genesis of the disorder, particularly with regard to
insulin function and body mass. No genome-wide association
studies have been conducted for BN or BED.
In their previous work (4) this investigative team advanced
the field using familial linkage analysis with whole-genome and
exome sequencing to identify two missense mutations: one in
a genome-wide significant linkage region within the estrogen-
related receptor alpha gene (ESRRA) and another within
a suggestive linkage region in the histone deacetylase 4
gene (HDAC4). Histone acetylation/deacetylation alters chro-
mosome structure and affects transcription factor access
to DNA. HDAC4 represses transcription when tethered
to a promoter (https://www.ncbi.nlm.nih.gov/gene?Db=ge
ne&Cmd=ShowDetailView&TermToSearch=9759). Specifi-
cally, a mutation causing an alanine to threonine substitution
at amino acid 786 was found via exome sequencing of a large
family with multiple cases of AN and BN as well as subthres-
hold/unspecified eating disorders. The human HDAC4A786T
mutation lies at the junction of two protein domains of HDAC4,
is relatively common (at .0.2% in allele frequency), and is
predicted by bioinformatic analyses to be either benign or
mildly deleterious.
Thus, while the linkage evidence is suggestive and the
variant lies on the linkage haplotype, it is unclear if the variant
is functionally related to eating disorders. Lutter et al.
(1) address this issue by studying an equivalent mutation
introduced into the mouse HDAK4 protein at amino acid 778(HDAC4A778T) followed by an array of behavioral tests on
heterozygous mice that parallel symptoms characteristic of
human eating disorders; namely anxiety, despair, compulsiv-
ity, and fat responsiveness. Several behaviors were affected,
including weight dysregulation and hyper- rather than hypo-
phagia (more relevant to BN and BED than to AN). Critical for
the understanding of AN and BN, the authors did conduct sex-
specific studies. In addition, they cleverly introduced an
environmental stressor into their paradigms by testing mice
either singly or group housed. This latter parameter is relevant
given the widespread assumption that eating disorders arise
from a perfect storm of both genetic and environmental risk
factors.
Potentially informing the grossly disproportionate sex dif-
ference in AN and BN, male heterozygous mice displayed no
metabolic or behavioral differences in either the individual- or
group-housed conditions. Why remains a mystery. However,
female mice that were individually housed displayed
decreased responding for high-fat (i.e., rewarding) pellets
and increased compulsive grooming. These results parallel
fat avoidance in AN (5) as well as increased obsessive-
compulsive behaviors reflected in clinical comorbidity and twin-
based correlations between AN and obsessive-compulsive
disorder (6), and single nucleotide polymorphism–based
genetic correlations between AN and obsessive-compulsive
disorder (7). Observations in group-housed female mice
diverged in that they displayed increased weight gain on a
high-fat diet, decreased behavioral despair (took them longer
to give up in a force swim test), and increased anxiety. The
authors interpret the results of the forced swim test to be
associated with “jitteriness/anxiety syndrome” rather than
behavioral despair. However, the mouse behavior could also
reflect the behavioral symptom of heightened physical activity
in AN, where patients continue to engage in high levels of
physical activity even when acutely ill (8). One important point
to raise is that the behaviors observed in these mice cut
across eating disorder presentations, displaying abnormalities
that alternately reflect AN or BN/BED. Given the frequency
with which diagnostic crossover occurs in eating disorders (9),
this is not necessarily a problem; however, future work should
take care to disambiguate symptoms associated with specific
eating disorder presentations.
The authors also collected tissue and conducted a targeted
brain gene expression analysis of HDAC4 target genes in cortex
tissues from the HDAC4A778T mice as well as previously stored
brain tissue for a similar experiment in Esrrsa-null mice. Notably,
they found gene expression changes in six of seven target
genes by task, but only in the group-housed mice. Although this
is congruent with a potential gene-environment interaction,
it could also represent the effects of a potential environmental 
confounder caused by the group housing. While the results of 
the gene expression analyses are promising, genome-wide 
RNA sequencing analyses or an analysis of a broader panel 
of genes could have addressed possible confounding.
Their previous work on ESRRA led them to the hypothesis 
that disruption of the HDAC-ESRRA activity may function 
by interrupting mitochondrial function—more specifically, 
mitochondrial biogenesis. Although they did not provide 
experimental evidence that the HDAC variant exerts its 
effects via mitochondrial biogenesis, continued investigation 
of this hypothesis is worthwhile. Lindfors et al. (10) contend 
that the anorexia and hypothalamic neurodegeneration of 
the anx/anx mouse (an animal model of some facets of AN) 
may be associated with dysfunction of the mitochondrial 
complex.
The work by Lutter et al. (1) is a valuable contribution to the 
growing body of literature elucidating the biological etiology of 
eating disorders. Concerted efforts are required across meth-
odologies to complete the puzzle. It is unconscionable that 
individuals continue to die from AN. Despite decades of study, 
our evidence for the treatment of AN remains meager. 
Although family-based interventions are fairly effective for 
youth, treatment of adults is unacceptably poor. Moreover, 
we have no medications that are effective in the treatment of 
the illness. This comes as no surprise given our incomplete 
understanding of its biology.
Our recent genome-wide association work demonstrates 
significant negative genetic correlations between AN and body 
mass index and other unfavorable metabolic parameters (2), 
and supports the current findings of Lutter et al. These and 
other findings encourage an increased focus on metabolic 
aspects of AN. In a world where the prevalence of obesity 
continues to rise, and nonsurgical treatments for obesity are 
notoriously ineffective, individuals prone to AN have an 
unexplained ability to maintain dangerously low body mass 
indices. Rounding out our understanding of the biology of this 
extreme end of appetite and weight dysregulation may not 
only inform the development of effective therapeutics for 
eating disorders, but also contribute to enhanced understand-
ing of appetite and weight dysregulation in obesity.Acknowledgments and Disclosures
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